Athersys
Athersys is to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome
Rankings by
Национальный рейтинг393rd
in United States Региональный рейтинг447th
in North America and Caribbean Глобальный рейтинг1062nd
worldwide